We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Fair Isaac
FICO
$29.5B
| $295K | ﹤0.01% |
2,295
| – | – |
|
977
iShares Gold Trust
IAU
$63.2B
| $295K | ﹤0.01% |
12,350
-200
| -2% | -$4.7K |
|
|
CERN
978
DELISTED
Cerner Corp
CERN
| $295K | ﹤0.01% |
5,015
-1,494
| -23% | -$80.7K |
|
|
APU
979
DELISTED
AmeriGas Partners, L.P.
APU
| $295K | ﹤0.01% |
6,270
+1,000
| +19% | +$47.3K |
|
980
Brookfield
BN
$103B
| $294K | ﹤0.01% |
22,618
+488
| +2% | +$6.18K |
|
981
Westlake Corp
WLK
$9.36B
| $293K | ﹤0.01% |
4,448
-4,349
| -49% | -$275K |
|
982
Choice Hotels
CHH
$5.08B
| $291K | ﹤0.01% |
4,671
| – | – |
|
983
ATN International
ATNI
$364M
| $287K | ﹤0.01% |
+4,082
| New | +$311K |
|
984
Worthington Enterprises
WOR
$2.81B
| $286K | ﹤0.01% |
10,296
| – | – |
|
985
Archrock
AROC
$6.29B
| $284K | ﹤0.01% |
+22,925
| New | +$322K |
|
|
BRSL
986
Brightstar Lottery PLC
BRSL
$1.95B
| $284K | ﹤0.01% |
12,027
-465
| -4% | -$12.1K |
|
987
Usana Health Sciences
USNA
$397M
| $280K | ﹤0.01% |
+4,874
| New | +$291K |
|
988
Westamerica Bancorp
WABC
$1.39B
| $280K | ﹤0.01% |
5,030
| – | – |
|
989
NBT Bancorp
NBTB
$2.73B
| $279K | ﹤0.01% |
7,532
+136
| +2% | +$5.48K |
|
990
Patrick Industries
PATK
$2.82B
| $277K | ﹤0.01% |
+8,831
| New | +$305K |
|
|
ABAX
991
DELISTED
Abaxis Inc
ABAX
| $275K | ﹤0.01% |
5,691
-212
| -4% | -$10.5K |
|
992
HubSpot
HUBS
$11.1B
| $274K | ﹤0.01% |
4,533
-4,205
| -48% | -$238K |
|
993
Palo Alto Networks
PANW
$265B
| $273K | ﹤0.01% |
14,598
-5,112
| -26% | -$114K |
|
994
Manulife Financial
MFC
$73.2B
| $270K | ﹤0.01% |
15,234
-571
| -4% | -$10.5K |
|
995
Hilton Worldwide
HLT
$74.3B
| $268K | ﹤0.01% |
4,597
+4,087
| +801% | +$237K |
|
996
Vail Resorts
MTN
$5.4B
| $265K | ﹤0.01% |
+1,384
| New | +$245K |
|
|
GS.PRB.CL
997
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
| $265K | ﹤0.01% |
10,000
| – | – |
|
998
Columbia Sportswear
COLM
$3.17B
| $264K | ﹤0.01% |
4,523
| – | – |
|
|
ALXN
999
DELISTED
Alexion Pharmaceuticals
ALXN
| $264K | ﹤0.01% |
2,183
+138
| +7% | +$17.8K |
|
1000
Bread Financial
BFH
$4.36B
| $263K | ﹤0.01% |
1,328
-173,885
| -99% | -$32.9M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.